Immunovant Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Immunovant Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- IMVT
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001764013
Board of directors
-
Andrew J. Fromkin · DirectorSince 2023
-
Atul Pande · DirectorSince 2023
-
Douglas J. Hughes · DirectorSince 2023
-
Eric Venker · Director · Chief Executive OfficerSince 2025
-
Frank Torti · DirectorSince 2023
-
George Migausky V · DirectorSince 2023
-
Jake Bauer · DirectorSince 2025
-
Peter Salzmann · Director · Chief Executive OfficerSince 2023
-
Robert Graham Susman · DirectorSince 2025
Chief executives
Peter Salzmann
· Chief Executive Officer
Dates unknown
Eric Venker
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of September 2, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
91.9%
-
95.9%
Board connections
4 of this board's directors also sit on 5 other boards.
- via Frank Torti
- via Jake Bauer
- via Peter Salzmann
- via Jake Bauer
- via George Migausky V
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $349,999,986
- 1 purchase by 1 insider
- Sold, last 12 months
- $16,028,726
- 59 sales by 10 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 23, 2026 | Van Tuyl Christopher Officer (Chief Legal Officer) | Open-market sale | −2,846 | $36.36 | $103,481 |
| Aug 28, 2026 | Atul Pande Director | Option exercise | +1,500 | $8.43 | $12,645 |
| Aug 28, 2026 | Atul Pande Director | Open-market sale | −1,500 | $43.27 | $64,905 |
| Aug 20, 2026 | Gloria Melanie Officer (Chief Operating Officer) | Open-market sale | −3,056 | $44.16 | $134,953 |
| Jul 24, 2026 | Atul Pande Director | Option exercise | +1,500 | $8.43 | $12,645 |
| Jul 24, 2026 | Atul Pande Director | Open-market sale | −1,500 | $39.80 | $59,700 |
| Jul 23, 2026 | Girao Tiago Officer (Chief Financial Officer) | Open-market sale | −6,798 | $38.69 | $263,015 |
| Jul 23, 2026 | Stout Jay S Officer (Chief Technology Officer) | Open-market sale | −2,857 | $38.69 | $110,537 |
| Jul 8, 2026 | Gloria Melanie Officer (Chief Operating Officer) | Open-market sale | −1,930 | $39.53 | $76,293 |
| Jul 8, 2026 | Stout Jay S Officer (Chief Technology Officer) | Open-market sale | −1,906 | $39.53 | $75,344 |
| Jul 8, 2026 | Van Tuyl Christopher Officer (Chief Legal Officer) | Open-market sale | −1,143 | $39.53 | $45,183 |
| Jul 8, 2026 | Gloria Melanie Officer (Chief Operating Officer) | Open-market sale | −106 | $39.99 | $4,239 |
| Jul 8, 2026 | Stout Jay S Officer (Chief Technology Officer) | Open-market sale | −105 | $39.99 | $4,199 |
| Jul 8, 2026 | Van Tuyl Christopher Officer (Chief Legal Officer) | Open-market sale | −63 | $39.99 | $2,519 |
| Jul 8, 2026 | Stout Jay S Officer (Chief Technology Officer) | Open-market sale | −1,399 | $39.53 | $55,302 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.